265 related articles for article (PubMed ID: 34468179)
1. Coronaviruses construct an interconnection way with ERAD and autophagy.
Movaqar A; Yaghoubi A; Rezaee SR; Jamehdar SA; Soleimanpour S
Future Microbiol; 2021 Sep; 16(14):1135-1151. PubMed ID: 34468179
[TBL] [Abstract][Full Text] [Related]
2. Coronavirus interactions with the cellular autophagy machinery.
Miller K; McGrath ME; Hu Z; Ariannejad S; Weston S; Frieman M; Jackson WT
Autophagy; 2020 Dec; 16(12):2131-2139. PubMed ID: 32964796
[TBL] [Abstract][Full Text] [Related]
3. GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition.
Bestion E; Zandi K; Belouzard S; Andreani J; Lepidi H; Novello M; Rouquairol C; Baudoin JP; Rachid M; La Scola B; Mege JL; Dubuisson J; Schinazi RF; Mezouar S; Halfon P
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062337
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
[TBL] [Abstract][Full Text] [Related]
5. Canonical and Noncanonical Autophagy as Potential Targets for COVID-19.
Bello-Perez M; Sola I; Novoa B; Klionsky DJ; Falco A
Cells; 2020 Jul; 9(7):. PubMed ID: 32635598
[TBL] [Abstract][Full Text] [Related]
6. Human coronaviruses and therapeutic drug discovery.
Song LG; Xie QX; Lao HL; Lv ZY
Infect Dis Poverty; 2021 Mar; 10(1):28. PubMed ID: 33726861
[TBL] [Abstract][Full Text] [Related]
7. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
8. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
[TBL] [Abstract][Full Text] [Related]
9. Multi-level inhibition of coronavirus replication by chemical ER stress.
Shaban MS; Müller C; Mayr-Buro C; Weiser H; Meier-Soelch J; Albert BV; Weber A; Linne U; Hain T; Babayev I; Karl N; Hofmann N; Becker S; Herold S; Schmitz ML; Ziebuhr J; Kracht M
Nat Commun; 2021 Sep; 12(1):5536. PubMed ID: 34545074
[TBL] [Abstract][Full Text] [Related]
10. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses.
Siri M; Dastghaib S; Zamani M; Rahmani-Kukia N; Geraylow KR; Fakher S; Keshvarzi F; Mehrbod P; Ahmadi M; Mokarram P; Coombs KM; Ghavami S
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206057
[TBL] [Abstract][Full Text] [Related]
11. Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-
Anjum FR; Anam S; Abbas G; Mahmood MS; Rahman SU; Goraya MU; Abdullah RM; Luqman M; Ali A; Akram MK; Chaudhry TH
Viral Immunol; 2021 Jun; 34(5):321-329. PubMed ID: 33181057
[TBL] [Abstract][Full Text] [Related]
12. The Molecular Interplay between Human Coronaviruses and Autophagy.
Shroff A; Nazarko TY
Cells; 2021 Aug; 10(8):. PubMed ID: 34440791
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19.
Yang N; Shen HM
Int J Biol Sci; 2020; 16(10):1724-1731. PubMed ID: 32226290
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.
Zhu Y; Yu D; Hu Y; Wu T; Chong H; He Y
Signal Transduct Target Ther; 2021 Aug; 6(1):294. PubMed ID: 34344868
[No Abstract] [Full Text] [Related]
15. [Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors].
Tian L; Liu W; Sun L
Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):605-611. PubMed ID: 32347055
[TBL] [Abstract][Full Text] [Related]
16. Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection.
Aslam M; Ladilov Y
Cells; 2020 Aug; 9(9):. PubMed ID: 32854430
[TBL] [Abstract][Full Text] [Related]
17. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
18. Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
Morris G; Athan E; Walder K; Bortolasci CC; O'Neil A; Marx W; Berk M; Carvalho AF; Maes M; Puri BK
Life Sci; 2020 Dec; 262():118541. PubMed ID: 33035581
[TBL] [Abstract][Full Text] [Related]
19. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
20. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.
Persoons L; Vanderlinden E; Vangeel L; Wang X; Do NDT; Foo SC; Leyssen P; Neyts J; Jochmans D; Schols D; De Jonghe S
Antiviral Res; 2021 Sep; 193():105127. PubMed ID: 34217752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
